Innate Conformational Dynamics Drive Binding Specificity in Anti-Apoptotic Proteins Mcl-1 and Bcl-2

被引:2
|
作者
Wolf, Esther [1 ]
Lento, Cristina [1 ]
Pu, Jinyue [2 ]
Dickinson, Bryan C. [2 ]
Wilson, Derek J. [1 ]
机构
[1] York Univ, Dept Chem, Toronto, ON M3J 1P3, Canada
[2] Univ Chicago, Dept Chem, Chicago, IL 60637 USA
基金
加拿大自然科学与工程研究理事会; 美国国家卫生研究院;
关键词
MASS-SPECTROMETRY; BH3; DOMAINS; EXCHANGE; FAMILY; MITOCHONDRIA; INHIBITION; ACTIVATION; PEPTIDES; AFFINITY; LIGANDS;
D O I
10.1021/acs.biochem.2c00709
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The structurally conserved B-cell lymphoma 2 (Bcl-2)family ofprotein function to promote or inhibit apoptosis through an exceedinglycomplex web of specific, intrafamilial protein-protein interactions.The critical role of these proteins in lymphomas and other cancershas motivated a widespread interest in understanding the molecularmechanisms that drive specificity in Bcl-2 family interactions. However,the high degree of structural similarity among Bcl-2 homologues hasmade it difficult to rationalize the highly specific (and often divergent)binding behavior exhibited by these proteins using conventional structuralarguments. In this work, we use time-resolved hydrogen deuterium exchangemass spectrometry to explore shifts in conformational dynamics associatedwith binding partner engagement in the Bcl-2 family proteins Bcl-2and Mcl-1. Using this approach combined with homology modeling, wereveal that Mcl-1 binding is driven by a large-scale shift in conformationaldynamics, while Bcl-2 complexation occurs primarily through a classicalcharge compensation mechanism. This work has implications for understandingthe evolution of internally regulated biological systems composedof structurally similar proteins and for the development of drugstargeting Bcl-2 family proteins for promotion of apoptosis in cancer.
引用
收藏
页码:1619 / 1630
页数:12
相关论文
共 50 条
  • [41] Trends in targeting Bcl-2 anti-apoptotic proteins for cancer treatment
    Zhang, Zhenwei
    Bai, Lijun
    Hou, Linghui
    Deng, Hongguang
    Luan, Shenglin
    Liu, Dan
    Huang, Min
    Zhao, Linxiang
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 232
  • [42] Rise of the Selective Inhibitors of Anti-Apoptotic Bcl-2 Family Proteins
    Han, Li
    Wang, Renxiao
    CHEMMEDCHEM, 2013, 8 (09) : 1437 - 1440
  • [43] Targeting anti-apoptotic BCL-2 family proteins for cancer treatment
    Zhang, Xuan
    Liu, Xingui
    Zhou, Daohong
    Zheng, Guangrong
    FUTURE MEDICINAL CHEMISTRY, 2020, 12 (07) : 563 - 565
  • [44] Selective small molecule inhibition of anti-apoptotic MCL-1
    Cohen, Nicole A.
    Stewart, Michelle L.
    Gavathiotis, Evripidis
    Tepper, Jared L.
    Opferman, Joseph T.
    Walensky, Loren D.
    CANCER RESEARCH, 2012, 72
  • [45] Mcl-1 is an anti-apoptotic factor for human hepatocellular carcinoma
    Fleischer, B
    Schulze-Bergkamen, H
    Schuchmann, M
    Weber, A
    Biesterfeld, S
    Müller, M
    Krammer, PH
    Galle, PR
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2006, 28 (01) : 25 - 32
  • [46] Survival control of malignant lymphocytes by anti-apoptotic MCL-1
    Fernandez-Marrero, Y.
    Spinner, S.
    Kaufmann, T.
    Jost, P. J.
    LEUKEMIA, 2016, 30 (11) : 2152 - 2159
  • [47] Caspase dependent cleavage of the anti-apoptotic mcl-1 protein
    Michels, J
    O'Neill, JW
    Craig, R
    Johnson, PWM
    Packham, G
    BRITISH JOURNAL OF CANCER, 2002, 86 : S90 - S91
  • [48] Mechanism of apoptosis induction by inhibition of the anti-apoptotic BCL-2 proteins
    Chipuk, Jerry E.
    Fisher, John C.
    Dillon, Christopher P.
    Kriwacki, Richard W.
    Kuwana, Tomomi
    Green, Douglas R.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (51) : 20327 - 20332
  • [49] Anti-apoptotic BCL-2 family proteins in acute neural injury
    Anilkumar, Ujval
    Prehn, Jochen H. M.
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2014, 8
  • [50] Mcl-1 is a significant anti-apoptotic protein in pancreatic β-cells
    Liu, Siming
    Hu, Jiang
    Danial, Nika
    Kulkarni, Rohit N.
    DIABETES, 2008, 57 : A80 - A80